Fluorescence Spectroscopic Investigation of Competitive Interactions between Quercetin and Aflatoxin B₁ for Binding to Human Serum Albumin

• Published in: Toxins Vol. 11; no. 4; p. 214
• Main Authors: Tan, Hongxia, Chen, Lu, Ma, Liang, Liu, Shuang, Zhou, Hongyuan, Zhang, Yuhao, Guo, Ting, Liu, Wei, Dai, Hongjie, Yu, Yong
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.04.2019; MDPI
• Subjects: Aflatoxin B1; Aflatoxin B1 - chemistry; Aflatoxins; Agricultural production; Albumin; Animal feed; Binding; Binding Sites; Biocompatibility; Cereals; Competition; competitive interaction; Detoxification; Epidemiology; Experiments; Feeds; Flavonoids; Fluorescence; Fluorescence spectroscopy; Human serum albumin; Humans; In vivo methods and tests; Ligands; Mycotoxins; Nonsteroidal anti-inflammatory drugs; Protein Binding; Quercetin; Quercetin - chemistry; Serum albumin; Serum Albumin, Human - chemistry; Spectrometry, Fluorescence; Spectroscopic analysis; Spectroscopy; Spectrum analysis; Ultrafiltration; quercetin; fluorescence spectroscopy; aflatoxin B1; competitive interaction; human serum albumin
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins11040214

Aflatoxin B (AFB₁) is a highly toxic mycotoxin found worldwide in cereals, food, and animal feeds. AFB₁ binds to human serum albumin (HSA) with high affinity. In previous experiments, it has been revealed that reducing the binding rate of AFB₁ with HSA could speed up the elimination rate of AFB₁. Therefore, we examined the ability of quercetin to compete with AFB₁ for binding HSA by fluorescence spectroscopy, synchronous spectroscopy, ultrafiltration studies, etc. It was shown that AFB₁ and quercetin bind to HSA in the same Sudlow site Ӏ (subdomain IIA), and the binding constant (K ) of the quercetin-HSA complex is significantly stronger than the complex of AFB₁-HSA. Our data in this experiment showed that quercetin is able to remove the AFB₁ from HSA and reduce its bound fraction. This exploratory work may be of significance for studies in the future regarding decreasing its bound fraction and then increasing its elimination rate for detoxification. This exploratory study may initiate future epidemiological research designs to obtain further evidence of the long-term (potential protective) effects of competing substances on human patients.